Global Oncolytic Virus Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Oncolytic Virus market size was valued at USD 17 million in 2023 and is forecast to a readjusted size of USD 27 million by 2030 with a CAGR of 6.5% during review period.
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX?015),9 an E1B?deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T?Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM?CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.
The Global Info Research report includes an overview of the development of the Oncolytic Virus industry chain, the market status of Melanoma (Imlygic, Oncorine), Other Cancers (Imlygic, Oncorine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncolytic Virus.
Regionally, the report analyzes the Oncolytic Virus markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncolytic Virus market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oncolytic Virus market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncolytic Virus industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Imlygic, Oncorine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncolytic Virus market.
Regional Analysis: The report involves examining the Oncolytic Virus market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncolytic Virus market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oncolytic Virus:
Company Analysis: Report covers individual Oncolytic Virus players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncolytic Virus This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Melanoma, Other Cancers).
Technology Analysis: Report covers specific technologies relevant to Oncolytic Virus. It assesses the current state, advancements, and potential future developments in Oncolytic Virus areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncolytic Virus market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oncolytic Virus market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Oncolytic Virus product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus, with revenue, gross margin and global market share of Oncolytic Virus from 2019 to 2024.
Chapter 3, the Oncolytic Virus competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Oncolytic Virus market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus.
Chapter 13, to describe Oncolytic Virus research findings and conclusion.
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX?015),9 an E1B?deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T?Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM?CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.
The Global Info Research report includes an overview of the development of the Oncolytic Virus industry chain, the market status of Melanoma (Imlygic, Oncorine), Other Cancers (Imlygic, Oncorine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncolytic Virus.
Regionally, the report analyzes the Oncolytic Virus markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncolytic Virus market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oncolytic Virus market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncolytic Virus industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Imlygic, Oncorine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncolytic Virus market.
Regional Analysis: The report involves examining the Oncolytic Virus market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncolytic Virus market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oncolytic Virus:
Company Analysis: Report covers individual Oncolytic Virus players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncolytic Virus This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Melanoma, Other Cancers).
Technology Analysis: Report covers specific technologies relevant to Oncolytic Virus. It assesses the current state, advancements, and potential future developments in Oncolytic Virus areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncolytic Virus market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oncolytic Virus market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Imlygic
- Oncorine
- Others
- Melanoma
- Other Cancers
- Amgen
- Shanghai Sunway Biotech
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Oncolytic Virus product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus, with revenue, gross margin and global market share of Oncolytic Virus from 2019 to 2024.
Chapter 3, the Oncolytic Virus competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Oncolytic Virus market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus.
Chapter 13, to describe Oncolytic Virus research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Oncolytic Virus
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncolytic Virus by Type
1.3.1 Overview: Global Oncolytic Virus Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Oncolytic Virus Consumption Value Market Share by Type in 2023
1.3.3 Imlygic
1.3.4 Oncorine
1.3.5 Others
1.4 Global Oncolytic Virus Market by Application
1.4.1 Overview: Global Oncolytic Virus Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Melanoma
1.4.3 Other Cancers
1.5 Global Oncolytic Virus Market Size & Forecast
1.6 Global Oncolytic Virus Market Size and Forecast by Region
1.6.1 Global Oncolytic Virus Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Oncolytic Virus Market Size by Region, (2019-2030)
1.6.3 North America Oncolytic Virus Market Size and Prospect (2019-2030)
1.6.4 Europe Oncolytic Virus Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Oncolytic Virus Market Size and Prospect (2019-2030)
1.6.6 South America Oncolytic Virus Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Oncolytic Virus Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Oncolytic Virus Product and Solutions
2.1.4 Amgen Oncolytic Virus Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Shanghai Sunway Biotech
2.2.1 Shanghai Sunway Biotech Details
2.2.2 Shanghai Sunway Biotech Major Business
2.2.3 Shanghai Sunway Biotech Oncolytic Virus Product and Solutions
2.2.4 Shanghai Sunway Biotech Oncolytic Virus Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Shanghai Sunway Biotech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oncolytic Virus Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Oncolytic Virus by Company Revenue
3.2.2 Top 3 Oncolytic Virus Players Market Share in 2023
3.2.3 Top 6 Oncolytic Virus Players Market Share in 2023
3.3 Oncolytic Virus Market: Overall Company Footprint Analysis
3.3.1 Oncolytic Virus Market: Region Footprint
3.3.2 Oncolytic Virus Market: Company Product Type Footprint
3.3.3 Oncolytic Virus Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oncolytic Virus Consumption Value and Market Share by Type (2019-2024)
4.2 Global Oncolytic Virus Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oncolytic Virus Consumption Value Market Share by Application (2019-2024)
5.2 Global Oncolytic Virus Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Oncolytic Virus Consumption Value by Type (2019-2030)
6.2 North America Oncolytic Virus Consumption Value by Application (2019-2030)
6.3 North America Oncolytic Virus Market Size by Country
6.3.1 North America Oncolytic Virus Consumption Value by Country (2019-2030)
6.3.2 United States Oncolytic Virus Market Size and Forecast (2019-2030)
6.3.3 Canada Oncolytic Virus Market Size and Forecast (2019-2030)
6.3.4 Mexico Oncolytic Virus Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Oncolytic Virus Consumption Value by Type (2019-2030)
7.2 Europe Oncolytic Virus Consumption Value by Application (2019-2030)
7.3 Europe Oncolytic Virus Market Size by Country
7.3.1 Europe Oncolytic Virus Consumption Value by Country (2019-2030)
7.3.2 Germany Oncolytic Virus Market Size and Forecast (2019-2030)
7.3.3 France Oncolytic Virus Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Oncolytic Virus Market Size and Forecast (2019-2030)
7.3.5 Russia Oncolytic Virus Market Size and Forecast (2019-2030)
7.3.6 Italy Oncolytic Virus Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oncolytic Virus Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Oncolytic Virus Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Oncolytic Virus Market Size by Region
8.3.1 Asia-Pacific Oncolytic Virus Consumption Value by Region (2019-2030)
8.3.2 China Oncolytic Virus Market Size and Forecast (2019-2030)
8.3.3 Japan Oncolytic Virus Market Size and Forecast (2019-2030)
8.3.4 South Korea Oncolytic Virus Market Size and Forecast (2019-2030)
8.3.5 India Oncolytic Virus Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Oncolytic Virus Market Size and Forecast (2019-2030)
8.3.7 Australia Oncolytic Virus Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Oncolytic Virus Consumption Value by Type (2019-2030)
9.2 South America Oncolytic Virus Consumption Value by Application (2019-2030)
9.3 South America Oncolytic Virus Market Size by Country
9.3.1 South America Oncolytic Virus Consumption Value by Country (2019-2030)
9.3.2 Brazil Oncolytic Virus Market Size and Forecast (2019-2030)
9.3.3 Argentina Oncolytic Virus Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oncolytic Virus Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Oncolytic Virus Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Oncolytic Virus Market Size by Country
10.3.1 Middle East & Africa Oncolytic Virus Consumption Value by Country (2019-2030)
10.3.2 Turkey Oncolytic Virus Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Oncolytic Virus Market Size and Forecast (2019-2030)
10.3.4 UAE Oncolytic Virus Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Oncolytic Virus Market Drivers
11.2 Oncolytic Virus Market Restraints
11.3 Oncolytic Virus Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Oncolytic Virus Industry Chain
12.2 Oncolytic Virus Upstream Analysis
12.3 Oncolytic Virus Midstream Analysis
12.4 Oncolytic Virus Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Oncolytic Virus
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncolytic Virus by Type
1.3.1 Overview: Global Oncolytic Virus Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Oncolytic Virus Consumption Value Market Share by Type in 2023
1.3.3 Imlygic
1.3.4 Oncorine
1.3.5 Others
1.4 Global Oncolytic Virus Market by Application
1.4.1 Overview: Global Oncolytic Virus Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Melanoma
1.4.3 Other Cancers
1.5 Global Oncolytic Virus Market Size & Forecast
1.6 Global Oncolytic Virus Market Size and Forecast by Region
1.6.1 Global Oncolytic Virus Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Oncolytic Virus Market Size by Region, (2019-2030)
1.6.3 North America Oncolytic Virus Market Size and Prospect (2019-2030)
1.6.4 Europe Oncolytic Virus Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Oncolytic Virus Market Size and Prospect (2019-2030)
1.6.6 South America Oncolytic Virus Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Oncolytic Virus Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Oncolytic Virus Product and Solutions
2.1.4 Amgen Oncolytic Virus Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Shanghai Sunway Biotech
2.2.1 Shanghai Sunway Biotech Details
2.2.2 Shanghai Sunway Biotech Major Business
2.2.3 Shanghai Sunway Biotech Oncolytic Virus Product and Solutions
2.2.4 Shanghai Sunway Biotech Oncolytic Virus Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Shanghai Sunway Biotech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oncolytic Virus Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Oncolytic Virus by Company Revenue
3.2.2 Top 3 Oncolytic Virus Players Market Share in 2023
3.2.3 Top 6 Oncolytic Virus Players Market Share in 2023
3.3 Oncolytic Virus Market: Overall Company Footprint Analysis
3.3.1 Oncolytic Virus Market: Region Footprint
3.3.2 Oncolytic Virus Market: Company Product Type Footprint
3.3.3 Oncolytic Virus Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oncolytic Virus Consumption Value and Market Share by Type (2019-2024)
4.2 Global Oncolytic Virus Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oncolytic Virus Consumption Value Market Share by Application (2019-2024)
5.2 Global Oncolytic Virus Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Oncolytic Virus Consumption Value by Type (2019-2030)
6.2 North America Oncolytic Virus Consumption Value by Application (2019-2030)
6.3 North America Oncolytic Virus Market Size by Country
6.3.1 North America Oncolytic Virus Consumption Value by Country (2019-2030)
6.3.2 United States Oncolytic Virus Market Size and Forecast (2019-2030)
6.3.3 Canada Oncolytic Virus Market Size and Forecast (2019-2030)
6.3.4 Mexico Oncolytic Virus Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Oncolytic Virus Consumption Value by Type (2019-2030)
7.2 Europe Oncolytic Virus Consumption Value by Application (2019-2030)
7.3 Europe Oncolytic Virus Market Size by Country
7.3.1 Europe Oncolytic Virus Consumption Value by Country (2019-2030)
7.3.2 Germany Oncolytic Virus Market Size and Forecast (2019-2030)
7.3.3 France Oncolytic Virus Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Oncolytic Virus Market Size and Forecast (2019-2030)
7.3.5 Russia Oncolytic Virus Market Size and Forecast (2019-2030)
7.3.6 Italy Oncolytic Virus Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oncolytic Virus Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Oncolytic Virus Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Oncolytic Virus Market Size by Region
8.3.1 Asia-Pacific Oncolytic Virus Consumption Value by Region (2019-2030)
8.3.2 China Oncolytic Virus Market Size and Forecast (2019-2030)
8.3.3 Japan Oncolytic Virus Market Size and Forecast (2019-2030)
8.3.4 South Korea Oncolytic Virus Market Size and Forecast (2019-2030)
8.3.5 India Oncolytic Virus Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Oncolytic Virus Market Size and Forecast (2019-2030)
8.3.7 Australia Oncolytic Virus Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Oncolytic Virus Consumption Value by Type (2019-2030)
9.2 South America Oncolytic Virus Consumption Value by Application (2019-2030)
9.3 South America Oncolytic Virus Market Size by Country
9.3.1 South America Oncolytic Virus Consumption Value by Country (2019-2030)
9.3.2 Brazil Oncolytic Virus Market Size and Forecast (2019-2030)
9.3.3 Argentina Oncolytic Virus Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oncolytic Virus Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Oncolytic Virus Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Oncolytic Virus Market Size by Country
10.3.1 Middle East & Africa Oncolytic Virus Consumption Value by Country (2019-2030)
10.3.2 Turkey Oncolytic Virus Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Oncolytic Virus Market Size and Forecast (2019-2030)
10.3.4 UAE Oncolytic Virus Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Oncolytic Virus Market Drivers
11.2 Oncolytic Virus Market Restraints
11.3 Oncolytic Virus Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Oncolytic Virus Industry Chain
12.2 Oncolytic Virus Upstream Analysis
12.3 Oncolytic Virus Midstream Analysis
12.4 Oncolytic Virus Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Oncolytic Virus Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Oncolytic Virus Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Oncolytic Virus Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Oncolytic Virus Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Amgen Company Information, Head Office, and Major Competitors
Table 6. Amgen Major Business
Table 7. Amgen Oncolytic Virus Product and Solutions
Table 8. Amgen Oncolytic Virus Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Amgen Recent Developments and Future Plans
Table 10. Shanghai Sunway Biotech Company Information, Head Office, and Major Competitors
Table 11. Shanghai Sunway Biotech Major Business
Table 12. Shanghai Sunway Biotech Oncolytic Virus Product and Solutions
Table 13. Shanghai Sunway Biotech Oncolytic Virus Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Shanghai Sunway Biotech Recent Developments and Future Plans
Table 15. Global Oncolytic Virus Revenue (USD Million) by Players (2019-2024)
Table 16. Global Oncolytic Virus Revenue Share by Players (2019-2024)
Table 17. Breakdown of Oncolytic Virus by Company Type (Tier 1, Tier 2, and Tier 3)
Table 18. Market Position of Players in Oncolytic Virus, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 19. Head Office of Key Oncolytic Virus Players
Table 20. Oncolytic Virus Market: Company Product Type Footprint
Table 21. Oncolytic Virus Market: Company Product Application Footprint
Table 22. Oncolytic Virus New Market Entrants and Barriers to Market Entry
Table 23. Oncolytic Virus Mergers, Acquisition, Agreements, and Collaborations
Table 24. Global Oncolytic Virus Consumption Value (USD Million) by Type (2019-2024)
Table 25. Global Oncolytic Virus Consumption Value Share by Type (2019-2024)
Table 26. Global Oncolytic Virus Consumption Value Forecast by Type (2025-2030)
Table 27. Global Oncolytic Virus Consumption Value by Application (2019-2024)
Table 28. Global Oncolytic Virus Consumption Value Forecast by Application (2025-2030)
Table 29. North America Oncolytic Virus Consumption Value by Type (2019-2024) & (USD Million)
Table 30. North America Oncolytic Virus Consumption Value by Type (2025-2030) & (USD Million)
Table 31. North America Oncolytic Virus Consumption Value by Application (2019-2024) & (USD Million)
Table 32. North America Oncolytic Virus Consumption Value by Application (2025-2030) & (USD Million)
Table 33. North America Oncolytic Virus Consumption Value by Country (2019-2024) & (USD Million)
Table 34. North America Oncolytic Virus Consumption Value by Country (2025-2030) & (USD Million)
Table 35. Europe Oncolytic Virus Consumption Value by Type (2019-2024) & (USD Million)
Table 36. Europe Oncolytic Virus Consumption Value by Type (2025-2030) & (USD Million)
Table 37. Europe Oncolytic Virus Consumption Value by Application (2019-2024) & (USD Million)
Table 38. Europe Oncolytic Virus Consumption Value by Application (2025-2030) & (USD Million)
Table 39. Europe Oncolytic Virus Consumption Value by Country (2019-2024) & (USD Million)
Table 40. Europe Oncolytic Virus Consumption Value by Country (2025-2030) & (USD Million)
Table 41. Asia-Pacific Oncolytic Virus Consumption Value by Type (2019-2024) & (USD Million)
Table 42. Asia-Pacific Oncolytic Virus Consumption Value by Type (2025-2030) & (USD Million)
Table 43. Asia-Pacific Oncolytic Virus Consumption Value by Application (2019-2024) & (USD Million)
Table 44. Asia-Pacific Oncolytic Virus Consumption Value by Application (2025-2030) & (USD Million)
Table 45. Asia-Pacific Oncolytic Virus Consumption Value by Region (2019-2024) & (USD Million)
Table 46. Asia-Pacific Oncolytic Virus Consumption Value by Region (2025-2030) & (USD Million)
Table 47. South America Oncolytic Virus Consumption Value by Type (2019-2024) & (USD Million)
Table 48. South America Oncolytic Virus Consumption Value by Type (2025-2030) & (USD Million)
Table 49. South America Oncolytic Virus Consumption Value by Application (2019-2024) & (USD Million)
Table 50. South America Oncolytic Virus Consumption Value by Application (2025-2030) & (USD Million)
Table 51. South America Oncolytic Virus Consumption Value by Country (2019-2024) & (USD Million)
Table 52. South America Oncolytic Virus Consumption Value by Country (2025-2030) & (USD Million)
Table 53. Middle East & Africa Oncolytic Virus Consumption Value by Type (2019-2024) & (USD Million)
Table 54. Middle East & Africa Oncolytic Virus Consumption Value by Type (2025-2030) & (USD Million)
Table 55. Middle East & Africa Oncolytic Virus Consumption Value by Application (2019-2024) & (USD Million)
Table 56. Middle East & Africa Oncolytic Virus Consumption Value by Application (2025-2030) & (USD Million)
Table 57. Middle East & Africa Oncolytic Virus Consumption Value by Country (2019-2024) & (USD Million)
Table 58. Middle East & Africa Oncolytic Virus Consumption Value by Country (2025-2030) & (USD Million)
Table 59. Oncolytic Virus Raw Material
Table 60. Key Suppliers of Oncolytic Virus Raw Materials
Table 1. Global Oncolytic Virus Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Oncolytic Virus Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Oncolytic Virus Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Oncolytic Virus Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Amgen Company Information, Head Office, and Major Competitors
Table 6. Amgen Major Business
Table 7. Amgen Oncolytic Virus Product and Solutions
Table 8. Amgen Oncolytic Virus Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Amgen Recent Developments and Future Plans
Table 10. Shanghai Sunway Biotech Company Information, Head Office, and Major Competitors
Table 11. Shanghai Sunway Biotech Major Business
Table 12. Shanghai Sunway Biotech Oncolytic Virus Product and Solutions
Table 13. Shanghai Sunway Biotech Oncolytic Virus Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Shanghai Sunway Biotech Recent Developments and Future Plans
Table 15. Global Oncolytic Virus Revenue (USD Million) by Players (2019-2024)
Table 16. Global Oncolytic Virus Revenue Share by Players (2019-2024)
Table 17. Breakdown of Oncolytic Virus by Company Type (Tier 1, Tier 2, and Tier 3)
Table 18. Market Position of Players in Oncolytic Virus, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 19. Head Office of Key Oncolytic Virus Players
Table 20. Oncolytic Virus Market: Company Product Type Footprint
Table 21. Oncolytic Virus Market: Company Product Application Footprint
Table 22. Oncolytic Virus New Market Entrants and Barriers to Market Entry
Table 23. Oncolytic Virus Mergers, Acquisition, Agreements, and Collaborations
Table 24. Global Oncolytic Virus Consumption Value (USD Million) by Type (2019-2024)
Table 25. Global Oncolytic Virus Consumption Value Share by Type (2019-2024)
Table 26. Global Oncolytic Virus Consumption Value Forecast by Type (2025-2030)
Table 27. Global Oncolytic Virus Consumption Value by Application (2019-2024)
Table 28. Global Oncolytic Virus Consumption Value Forecast by Application (2025-2030)
Table 29. North America Oncolytic Virus Consumption Value by Type (2019-2024) & (USD Million)
Table 30. North America Oncolytic Virus Consumption Value by Type (2025-2030) & (USD Million)
Table 31. North America Oncolytic Virus Consumption Value by Application (2019-2024) & (USD Million)
Table 32. North America Oncolytic Virus Consumption Value by Application (2025-2030) & (USD Million)
Table 33. North America Oncolytic Virus Consumption Value by Country (2019-2024) & (USD Million)
Table 34. North America Oncolytic Virus Consumption Value by Country (2025-2030) & (USD Million)
Table 35. Europe Oncolytic Virus Consumption Value by Type (2019-2024) & (USD Million)
Table 36. Europe Oncolytic Virus Consumption Value by Type (2025-2030) & (USD Million)
Table 37. Europe Oncolytic Virus Consumption Value by Application (2019-2024) & (USD Million)
Table 38. Europe Oncolytic Virus Consumption Value by Application (2025-2030) & (USD Million)
Table 39. Europe Oncolytic Virus Consumption Value by Country (2019-2024) & (USD Million)
Table 40. Europe Oncolytic Virus Consumption Value by Country (2025-2030) & (USD Million)
Table 41. Asia-Pacific Oncolytic Virus Consumption Value by Type (2019-2024) & (USD Million)
Table 42. Asia-Pacific Oncolytic Virus Consumption Value by Type (2025-2030) & (USD Million)
Table 43. Asia-Pacific Oncolytic Virus Consumption Value by Application (2019-2024) & (USD Million)
Table 44. Asia-Pacific Oncolytic Virus Consumption Value by Application (2025-2030) & (USD Million)
Table 45. Asia-Pacific Oncolytic Virus Consumption Value by Region (2019-2024) & (USD Million)
Table 46. Asia-Pacific Oncolytic Virus Consumption Value by Region (2025-2030) & (USD Million)
Table 47. South America Oncolytic Virus Consumption Value by Type (2019-2024) & (USD Million)
Table 48. South America Oncolytic Virus Consumption Value by Type (2025-2030) & (USD Million)
Table 49. South America Oncolytic Virus Consumption Value by Application (2019-2024) & (USD Million)
Table 50. South America Oncolytic Virus Consumption Value by Application (2025-2030) & (USD Million)
Table 51. South America Oncolytic Virus Consumption Value by Country (2019-2024) & (USD Million)
Table 52. South America Oncolytic Virus Consumption Value by Country (2025-2030) & (USD Million)
Table 53. Middle East & Africa Oncolytic Virus Consumption Value by Type (2019-2024) & (USD Million)
Table 54. Middle East & Africa Oncolytic Virus Consumption Value by Type (2025-2030) & (USD Million)
Table 55. Middle East & Africa Oncolytic Virus Consumption Value by Application (2019-2024) & (USD Million)
Table 56. Middle East & Africa Oncolytic Virus Consumption Value by Application (2025-2030) & (USD Million)
Table 57. Middle East & Africa Oncolytic Virus Consumption Value by Country (2019-2024) & (USD Million)
Table 58. Middle East & Africa Oncolytic Virus Consumption Value by Country (2025-2030) & (USD Million)
Table 59. Oncolytic Virus Raw Material
Table 60. Key Suppliers of Oncolytic Virus Raw Materials
LIST OF FIGURES
Figure 1. Oncolytic Virus Picture
Figure 2. Global Oncolytic Virus Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Oncolytic Virus Consumption Value Market Share by Type in 2023
Figure 4. Imlygic
Figure 5. Oncorine
Figure 6. Others
Figure 7. Global Oncolytic Virus Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Oncolytic Virus Consumption Value Market Share by Application in 2023
Figure 9. Melanoma Picture
Figure 10. Other Cancers Picture
Figure 11. Global Oncolytic Virus Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Oncolytic Virus Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Oncolytic Virus Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Oncolytic Virus Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Oncolytic Virus Consumption Value Market Share by Region in 2023
Figure 16. North America Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Oncolytic Virus Revenue Share by Players in 2023
Figure 22. Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Oncolytic Virus Market Share in 2023
Figure 24. Global Top 6 Players Oncolytic Virus Market Share in 2023
Figure 25. Global Oncolytic Virus Consumption Value Share by Type (2019-2024)
Figure 26. Global Oncolytic Virus Market Share Forecast by Type (2025-2030)
Figure 27. Global Oncolytic Virus Consumption Value Share by Application (2019-2024)
Figure 28. Global Oncolytic Virus Market Share Forecast by Application (2025-2030)
Figure 29. North America Oncolytic Virus Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Oncolytic Virus Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Oncolytic Virus Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Oncolytic Virus Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Oncolytic Virus Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Oncolytic Virus Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 39. France Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Oncolytic Virus Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Oncolytic Virus Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Oncolytic Virus Consumption Value Market Share by Region (2019-2030)
Figure 46. China Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 49. India Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Oncolytic Virus Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Oncolytic Virus Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Oncolytic Virus Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Oncolytic Virus Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Oncolytic Virus Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Oncolytic Virus Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 63. Oncolytic Virus Market Drivers
Figure 64. Oncolytic Virus Market Restraints
Figure 65. Oncolytic Virus Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Oncolytic Virus in 2023
Figure 68. Manufacturing Process Analysis of Oncolytic Virus
Figure 69. Oncolytic Virus Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Oncolytic Virus Picture
Figure 2. Global Oncolytic Virus Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Oncolytic Virus Consumption Value Market Share by Type in 2023
Figure 4. Imlygic
Figure 5. Oncorine
Figure 6. Others
Figure 7. Global Oncolytic Virus Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Oncolytic Virus Consumption Value Market Share by Application in 2023
Figure 9. Melanoma Picture
Figure 10. Other Cancers Picture
Figure 11. Global Oncolytic Virus Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Oncolytic Virus Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Oncolytic Virus Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Oncolytic Virus Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Oncolytic Virus Consumption Value Market Share by Region in 2023
Figure 16. North America Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Oncolytic Virus Revenue Share by Players in 2023
Figure 22. Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Oncolytic Virus Market Share in 2023
Figure 24. Global Top 6 Players Oncolytic Virus Market Share in 2023
Figure 25. Global Oncolytic Virus Consumption Value Share by Type (2019-2024)
Figure 26. Global Oncolytic Virus Market Share Forecast by Type (2025-2030)
Figure 27. Global Oncolytic Virus Consumption Value Share by Application (2019-2024)
Figure 28. Global Oncolytic Virus Market Share Forecast by Application (2025-2030)
Figure 29. North America Oncolytic Virus Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Oncolytic Virus Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Oncolytic Virus Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Oncolytic Virus Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Oncolytic Virus Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Oncolytic Virus Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 39. France Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Oncolytic Virus Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Oncolytic Virus Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Oncolytic Virus Consumption Value Market Share by Region (2019-2030)
Figure 46. China Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 49. India Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Oncolytic Virus Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Oncolytic Virus Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Oncolytic Virus Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Oncolytic Virus Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Oncolytic Virus Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Oncolytic Virus Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Oncolytic Virus Consumption Value (2019-2030) & (USD Million)
Figure 63. Oncolytic Virus Market Drivers
Figure 64. Oncolytic Virus Market Restraints
Figure 65. Oncolytic Virus Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Oncolytic Virus in 2023
Figure 68. Manufacturing Process Analysis of Oncolytic Virus
Figure 69. Oncolytic Virus Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
